Device Trial Radar · NCT05554471
Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression
Last checked: Nov 20, 2026Latest source record: Apr 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
352
Actual
Start
Aug 30, 2022
Primary completion
Jul 11, 2023
Study completion Jul 11, 2023
Sponsor
- Lead sponsor
- Cordis US Corp.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- NAMSA
- First posted
- Sep 26, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
ReliaSeal is a clinical trial designed to evaluate safety and efficacy of use of MYNX CONTROL™ Venous Vascular Closure Device 6F-12F vs. manual compression to seal femoral access sites in patients who have undergone endovascular procedures utilizing up to 12F procedural sheaths in one or both limbs.
Conditions
- Venous Vascular Closure
Interventions
MYNX CONTROL™ Venous Vascular Closure Device 6F-12FDevice
Mynx Control Venous VCD 6F-12F is indicated for use to seal femoral venous access sites while reducing times to hemostasis and ambulation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety Endpoint: Major Complications of the Target Limb Access Site Within 30 DaysTime frame: 30 days post procedure
- Primary Effectiveness Endpoint: Time to AmbulationTime frame: Post procedure
- Primary Effectiveness Endpoint: Time to HemostasisTime frame: Post procedure
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Arizona Cardiovascular Research Center
Phoenix, Arizona
Colorado Heart and Vascular PC
Lakewood, Colorado
Baptist Health Miami Cardiac and Vascular Institute
Miami, Florida
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.